Valeant Pharmaceutical's head office is seen in Laval. The claim filed against Valeant Pharmaceuticals says it used a secret pharmacy network, deceptive pricing and reimbursement practices, and fictitious accounting. T. Rowe Price, along with Alleghany Corp, is suing Valeant, its former chief executive and several current and former executives. Once a fervent defender and third-largest investor, T. Rowe Price sold most of its shares in May. Article Continued BelowIn a statement, Valeant said it’s aware of the lawsuit, which is similar to a claim filed in October by a teacher’s retirement fund.

Source: thestar August 18, 2016 21:33 UTC